MORRISVILLE, N.C. & BILLINGHAM, United Kingdom--(BUSINESS WIRE)--Fujifilm Diosynth Biotechnologies is expanding its existing contract manufacturing capabilities with the addition of a 1,000L ...
A rendering of the $2 billion cell culture manufacturing facility for which Fujifilm Diosynth Biotechnologies broke ground last week in Holly Springs, NC. [Fujifilm Diosynth Biotechnologies] The cell ...
FUJIFILM Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreactors. One each of these is being ...
TOKYO, April 11, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Corporation today announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO* Business to further expand the planned FUJIFILM ...
(RTTNews) - Jacobs Solutions Inc. (J) announced on Thursday that it was chosen by Fuji Film Diosynth Biotechnologies to assist in the $1.2 billion expansion of an end-to-end, large-scale cell culture ...
Human induced pluripotent stem cells (hiPSCs) are considered a promising tool in medicine, with the potential to unlock ...
Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results